about
Major physical and psychological harms of methamphetamine useSuicide among heroin users: rates, risk factors and methods.A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions.Investigating the co-occurrence of self-mutilation and suicide attempts among opioid-dependent individuals.The monitoring of drug trends in Australia.Regular cocaine use is associated with increased systolic blood pressure, aortic stiffness and left ventricular mass in young otherwise healthy individualsHeroin overdose: research and evidence-based intervention.Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates.Attempted suicide among injecting and noninjecting cocaine users in Sydney, Australia.Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study.Methamphetamine and cardiovascular pathology: a review of the evidence.Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.Are non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlatesImpulsivity and borderline personality as risk factors for suicide attempts among opioid-dependent individuals.Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.The toxicology of homicide offenders and victims: A review.The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?Pathways to heroin dependence: time to re-appraise self-medication.Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment.Heroin overdose.Trajectories of heroin use: 10-11-year findings from the Australian Treatment Outcome Study.Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015.Changes and predictors of change in the physical health status of heroin users over 24 months.Stroke and methamphetamine use in young adults: a review.Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study.The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.Which medications are suitable for agonist drug maintenance?Characteristics, circumstances and pathology of sudden or unnatural deaths of cases with evidence of pathological hoarding.Prevalence and Correlates of Suicidal Thoughts and Suicide Attempts in People Prescribed Pharmaceutical Opioids for Chronic Pain.Can we predict retention in longitudinal studies of substance use? Findings from the Australian Treatment Outcome Study.Associations of borderline personality with pain, problems with medications and suicidality in a community sample of chronic non-cancer pain patients prescribed opioids for pain.Patterns and correlates of alcohol use amongst heroin users: 11-year follow-up of the Australian Treatment Outcome Study cohort.Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England.The health consequences of injecting tablet preparations: foreign body pulmonary embolization and pulmonary hypertension among deceased injecting drug users.The prevalence and correlates of chronic pain and suicidality in a nationally representative sample.Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study.Patterns of major depression and drug-related problems amongst heroin users across 36 months.Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence.Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS).The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
P50
Q28274034-C91E71B9-7970-4420-892D-35754DA15E3DQ34157262-EC511CDD-BD08-413F-8EF6-EC7B358969D7Q34348610-37E47FCB-D45D-49BA-ADDC-CEDFD95035D3Q34775027-CA6AB5FB-42B6-46E9-8973-30B680BEC161Q35126880-7C2D650C-99CA-4408-A5F7-BB282F4F5AE4Q35143616-FB3F5F0C-6132-477B-B1B3-5B7C0413E9BCQ35147553-615F5282-80F4-4CAA-830F-A769B6534D53Q36056071-0ABC5F82-AA80-4849-BB55-7C67AD4ECE48Q36272368-6D1BB180-28AC-4462-A11F-B41E3DFF75DFQ36440646-98CC643A-E34E-4042-8105-2A2941FF9CA4Q36848266-DDF258B3-064A-4865-A619-2E974DA35D6EQ37294521-C6AC6215-CF74-40DF-821B-498D53C8E332Q37314715-5035121E-2A32-4538-8153-B3F7FBA0D294Q37366362-C0D715E2-6646-47E6-BADF-3B3A04417498Q37552221-464BFAA2-CE04-49C8-8C8E-0D416DBAE10AQ37743716-B55429E7-434B-4579-B8E9-F18A84F50BDBQ37982103-DBDEC8D9-46ED-437B-84D2-77F921E1327AQ38052920-C005170A-093F-48C0-9890-0363175C7E1DQ38181184-F2E85F9B-5CF0-4B2A-91D4-F1CCA01210F8Q38924356-E2745C4B-B588-491B-B61C-F6189DE3A3E8Q39035991-43342AFE-E967-47E6-AE8C-D09E2CB17B6BQ39883364-A407E0E4-A37E-412F-8046-390E7D6C3303Q40003693-1BE8732D-5DBF-4091-98FF-671E430D3097Q40073047-FCB187E2-65E5-470F-8892-54E810EB3C69Q40163959-82A47356-D6C2-4B91-9946-0CB80FB6375AQ40171406-A57EBA39-017E-49F8-85B0-552EB11AAD70Q40390581-A58697D5-BC67-4618-AB79-251799709EBAQ40420017-B21D5428-224B-432A-8F63-5E557856A595Q40620218-AB483913-9243-4FC6-A06A-5F58CFE507ACQ40696093-5F7982DF-449A-4E8B-BA46-613C648818B5Q40796145-FE1BC644-6ACC-49D3-8429-7CFB348295F3Q40796858-79B8075C-F162-476E-AD62-3FC6EB151387Q40976608-CD181358-D220-47D1-AD77-DF8BA6E186ADQ41161455-0BF37D19-B6A1-43EC-BDDF-FFD44D98646AQ41385103-B5D80D42-393C-4F46-A4F2-8F9A0B911D49Q41530348-CCBBF142-B9B4-4DCE-AD5A-2DEC793B7DC4Q42612244-6FDA524B-7913-47EE-A303-B8384507221EQ42623638-CA82EAAD-7309-4AAF-9E6F-9ED26AB9009CQ42624436-4AA09A90-4758-456F-9A52-3F443516A9EBQ42636730-A157B636-64B6-4A29-94B7-A11B303ACB49
P50
name
Shane Darke
@en
Shane Darke
@nl
type
label
Shane Darke
@en
Shane Darke
@nl
prefLabel
Shane Darke
@en
Shane Darke
@nl